News About: Pharm. Affairs
Samsung Bioepis agrees on ‘SB5’ patent conflict with AbbVie
Samsung Bioepis(CEO/President Han-Seung Ko) agreed on the patent conflict about SB5(generic name: adalimumab, biosimilar referencing Humira), a biosimilar for the treatment of autoimmune disease(Anti-TNF-α).
Samsung ...
Bsivo enters Samsung Medical Center after Severance and Seoul National University Hospital
‘Besivo Tab,’ an Ildong Pharmaceutical’s new chronic hepatitis B treatment, landed in Samsung Medical Center.
‘Besivo’ is increasing a chance to enlarge its market by entering major general hospitals from Severance H...
‘Dupilumab,’ moderate-to-severe eczema therapy, lands in Korea
‘Dupilumab,’ a moderate-to-severe eczema treatment for adults, will land in the Korean market.
As of 30 March, the Ministry of Food and Drug Safety(MFDS) approved Sanofi-Aventis Korea’s ‘Dupixent Prefilled Inj 300mg(...
Kyowa Hakko Kirin’s Neulasta meeting better health insurance benefits
The health insurance standards of Kyowa Hakko Kirin Korea’s Neulasta Prefilled Syringe(generic name: pegfilgrastim) has been partially extensively applied since 1 April.
Neulasta is a daily long-acting drug out of gr...
167 products including ‘Iclusig’ newly registered for National Health Insurance Service
Next month, 167 products including a leukemia therapy ‘Iclusig’ will be applied for the National Health Insurance Service.
The Ministry of Health and Welfare revised and announced the ‘Drug Insurance Benefits List an...
Fueled competition over hair loss treatment for 10 million patients in Korea
The number of hair loss patients has already exceeded ‘10 million’ in Korea. Multiple statistics analyzed the number will keep increasing in the future. As anyone can easily meet people with the hair loss issue due to...
KRW 70 billion release acetaminophen drug market in danger
The market of release acetaminophen drugs worth of about KRW 70 billion is in danger.
The Ministry of Health and Welfare(MFDS) distributed safety letters to medical experts and consumer organizations on the 13th and ...
Average annual increase rate of pharmacists was lowest compared to other health occupations
Among other types of health care providers, the increase rate of pharmacists was reportedly the lowest 1.2% for the past 6 years.
Also, 29,000 of total 34,000 pharmacists were working in pharmacies in 2016.
The Mini...
EC suspends approval of release-type acetaminophen, like Tylenol
The Ministry of Food and Drug Safety(Minister Young-Jin Ryu, MFDS) announced on the 13th the ministry has decided to distribute safety letters to pharmaceutical experts and consumer organizations in Korea as the Europ...
JW Pharmaceutical develops dutasteride tablet for treatment of hair loss and benign prostatic hyperplasia
Developing dutasteride as tablets, JW Pharmaceutical is going to target the world’s KRW 1 trillion market.
JW Pharmaceutical announced on the 12th the company succeeded in developing ‘dutasteride,’ a hair loss and be...
